FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048394016> ?p ?o ?g. }

• W3048394016 endingPage "1349" @default.
• W3048394016 startingPage "1340" @default.
• W3048394016 abstract "Our understanding of IgE-mediated drug allergy relies on the hapten concept, which is well established in inducing adaptive reactions of the immune system to small molecules like drugs. The role of hapten-carrier adducts in re-challenge reactions leading to mast cell degranulation and anaphylaxis is unclear. Based on clinical observations, the speed of adduct formation, skin and in vitro tests to inert drug molecules, a different explanation of IgE-mediated reactions to drugs is proposed: These are (a) A natural role of reduced mast cell (MC) reactivity in developing IgE-mediated reactions to drugs. This MC unresponsiveness is antigen-specific and covers the serum drug concentrations, but allows reactivity to locally higher concentrations. (b) Some non-covalent drug-protein complexes rely on rather affine bindings and have a similar appearance as covalent hapten-protein adducts. Such drug-protein complexes represent so-called fake antigens, as they are unable to induce immunity, but may react with and cross-link preformed drug-specific IgE. As they are formed very rapidly and in high concentrations, they may cause fulminant MC degranulation and anaphylaxis. (c) The generation of covalent hapten-protein adducts requires hours, either because the formation of covalent bonds requires time or because first a metabolic step for forming a reactive metabolite is required. This slow process of stable adduct formation has the advantage that it may give time to desensitize mast cells, even in already sensitized individuals. The consequences of this new interpretation of IgE-mediated reactions to drugs are potentially wide-reaching for IgE-mediated drug allergy but also allergy in general." @default.
• W3048394016 created "2020-08-18" @default.
• W3048394016 creator A5073211217 @default.
• W3048394016 date "2020-09-01" @default.
• W3048394016 modified "2023-10-13" @default.
• W3048394016 title "Anaphylaxis to drugs: Overcoming mast cell unresponsiveness by fake antigens" @default.
• W3048394016 cites W1494452958 @default.
• W3048394016 cites W1964880782 @default.
• W3048394016 cites W1973551977 @default.
• W3048394016 cites W1995307716 @default.
• W3048394016 cites W1999587831 @default.
• W3048394016 cites W2010040897 @default.
• W3048394016 cites W2010993054 @default.
• W3048394016 cites W2011841904 @default.
• W3048394016 cites W2032048270 @default.
• W3048394016 cites W2040943654 @default.
• W3048394016 cites W2056811697 @default.
• W3048394016 cites W2067038726 @default.
• W3048394016 cites W2073224154 @default.
• W3048394016 cites W2081389182 @default.
• W3048394016 cites W2087094124 @default.
• W3048394016 cites W2087926902 @default.
• W3048394016 cites W2100023667 @default.
• W3048394016 cites W2132369453 @default.
• W3048394016 cites W2134628252 @default.
• W3048394016 cites W2164740372 @default.
• W3048394016 cites W2283225864 @default.
• W3048394016 cites W2331639406 @default.
• W3048394016 cites W2514951894 @default.
• W3048394016 cites W2521400558 @default.
• W3048394016 cites W2527718275 @default.
• W3048394016 cites W2530506616 @default.
• W3048394016 cites W2611259443 @default.
• W3048394016 cites W2709053053 @default.
• W3048394016 cites W2778336362 @default.
• W3048394016 cites W2800484366 @default.
• W3048394016 cites W2901872876 @default.
• W3048394016 cites W2921620181 @default.
• W3048394016 cites W2944915877 @default.
• W3048394016 cites W2965880536 @default.
• W3048394016 cites W3009714550 @default.
• W3048394016 cites W3048394016 @default.
• W3048394016 cites W4236478916 @default.
• W3048394016 doi "https://doi.org/10.1111/all.14554" @default.
• W3048394016 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8247404" @default.
• W3048394016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32780486" @default.
• W3048394016 hasPublicationYear "2020" @default.
• W3048394016 type Work @default.
• W3048394016 sameAs 3048394016 @default.
• W3048394016 citedByCount "12" @default.
• W3048394016 countsByYear W30483940162020 @default.
• W3048394016 countsByYear W30483940162021 @default.
• W3048394016 countsByYear W30483940162022 @default.
• W3048394016 countsByYear W30483940162023 @default.
• W3048394016 crossrefType "journal-article" @default.
• W3048394016 hasAuthorship W3048394016A5073211217 @default.
• W3048394016 hasBestOaLocation W30483940161 @default.
• W3048394016 hasConcept C108204754 @default.
• W3048394016 hasConcept C141105273 @default.
• W3048394016 hasConcept C147483822 @default.
• W3048394016 hasConcept C159654299 @default.
• W3048394016 hasConcept C170493617 @default.
• W3048394016 hasConcept C178790620 @default.
• W3048394016 hasConcept C185592680 @default.
• W3048394016 hasConcept C203014093 @default.
• W3048394016 hasConcept C207480886 @default.
• W3048394016 hasConcept C2775933838 @default.
• W3048394016 hasConcept C2779726688 @default.
• W3048394016 hasConcept C29144244 @default.
• W3048394016 hasConcept C49802076 @default.
• W3048394016 hasConcept C55493867 @default.
• W3048394016 hasConcept C71924100 @default.
• W3048394016 hasConceptScore W3048394016C108204754 @default.
• W3048394016 hasConceptScore W3048394016C141105273 @default.
• W3048394016 hasConceptScore W3048394016C147483822 @default.
• W3048394016 hasConceptScore W3048394016C159654299 @default.
• W3048394016 hasConceptScore W3048394016C170493617 @default.
• W3048394016 hasConceptScore W3048394016C178790620 @default.
• W3048394016 hasConceptScore W3048394016C185592680 @default.
• W3048394016 hasConceptScore W3048394016C203014093 @default.
• W3048394016 hasConceptScore W3048394016C207480886 @default.
• W3048394016 hasConceptScore W3048394016C2775933838 @default.
• W3048394016 hasConceptScore W3048394016C2779726688 @default.
• W3048394016 hasConceptScore W3048394016C29144244 @default.
• W3048394016 hasConceptScore W3048394016C49802076 @default.
• W3048394016 hasConceptScore W3048394016C55493867 @default.
• W3048394016 hasConceptScore W3048394016C71924100 @default.
• W3048394016 hasIssue "5" @default.
• W3048394016 hasLocation W30483940161 @default.
• W3048394016 hasLocation W30483940162 @default.
• W3048394016 hasLocation W30483940163 @default.
• W3048394016 hasLocation W30483940164 @default.
• W3048394016 hasOpenAccess W3048394016 @default.
• W3048394016 hasPrimaryLocation W30483940161 @default.
• W3048394016 hasRelatedWork W1593550816 @default.
• W3048394016 hasRelatedWork W1980244606 @default.
• W3048394016 hasRelatedWork W2005452495 @default.
• W3048394016 hasRelatedWork W2018297739 @default.

• next